Folate supplements to prevent heart disease: "time is ripe" for clinical trials -- editorial.
This article was originally published in The Tan Sheet
Executive Summary
FOLATE SUPPLEMENTATION: "TIME IS RIPE" FOR CLINICAL TRIALS to determine whether folic acid supplements can prevent cardiovascular disease by reduc-ing homocysteine levels, Meir Stampfer, MD, Harvard School of Public Health, and Rene Malinow, MD, Oregon Regional Primate Research Center, suggested in an editorial in the Feb. 2 issue of New England Journal of Medicine. The editorial responds to a study by Jacob Selhub, PhD, Tufts University, et al., that appears in the same issue of the medical journal.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning